Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation (Q43125929)

14 November 2017

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation (English)

1 reference

14 November 2017

0 references

1 reference

17

1 reference

14 November 2017

Eugénie Lhommée

3

0 references

Patrick Mertens

object named as

Patrick Mertens

14

0 references

Anthonin Reilhac

object named as

Anthonin Reilhac

16

0 references

Paul Krack

26

object named as

Paul Krack

1 reference

14 November 2017

23

Alim-Louis Benabid

1 reference

14 November 2017

7

Valérie Fraix

1 reference

14 November 2017

25

Pierre Pollak

1 reference

14 November 2017

21

Jean-Louis Quesada

1 reference

14 November 2017

2

Claire Ardouin

1 reference

14 November 2017

5

Christelle Lagrange

1 reference

14 November 2017

Stéphane Thobois

1

1 reference

14 November 2017

Hélène Klinger

4

1 reference

14 November 2017

Jing Xie

6

1 reference

14 November 2017

Maria Clara Coelho Braga

8

1 reference

14 November 2017

Rachid Hassani

9

1 reference

14 November 2017

Andrea Kistner

10

1 reference

14 November 2017

Alexandra Juphard

11

1 reference

14 November 2017

Eric Seigneuret

12

1 reference

14 November 2017

Stephan Chabardes

13

1 reference

14 November 2017

Gustavo Polo

15

1 reference

14 November 2017

Didier LeBars

18

1 reference

14 November 2017

Marc Savasta

19

1 reference

14 November 2017

Léon Tremblay

20

1 reference

14 November 2017

Jean-Luc Bosson

22

1 reference

14 November 2017

Emmanuel Broussolle

24

1 reference

14 November 2017

language of work or name

English

0 references

publication date

17 March 2010

1 reference

14 November 2017

1 reference

14 November 2017

133

1 reference

14 November 2017

Pt 4

1 reference

14 November 2017

1111-1127

1 reference

The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease.

14 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Basolateral amygdala neurons facilitate reward-seeking behavior by exciting nucleus accumbens neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

The behavioural and motor consequences of focal lesions of the basal ganglia in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Frequency of New-Onset Pathologic Compulsive Gambling or Hypersexuality After Drug Treatment of Idiopathic Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum: immunohistochemical detection of retrogradely transported fluoro-gold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Negative symptoms: the 'pathology' of motivation and goal-directed behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Apathy and verbal fluency in STN-stimulated PD patients. An observational follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Functional abnormalities underlying pathological gambling in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Pathological gambling caused by drugs used to treat Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Characteristics of apathy in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Dopamine dysregulation syndrome in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Compulsive drug use linked to sensitized ventral striatal dopamine transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Parkinson's disease dementia--a first step?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Cognitive outcomes after deep brain stimulation for Parkinson's disease: a review of initial studies and recommendations for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Mapping neuroreceptors at work: on the definition and interpretation of binding potentials after 20 years of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Behavioural disorders, Parkinson's disease and subthalamic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Is the mesocortical dopaminergic system involved in Parkinson disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Dopamine in amygdala gates limbic processing of aversive stimuli in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Dissociating apathy and depression in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Mirthful laughter induced by subthalamic nucleus stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Pure psychic akinesia with bilateral lesions of basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

The emotional brain, fear, and the amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

21 January 2018

The Parkinson chimera

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

21 January 2018

Apathy is not depression

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Differential limbic--cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Posterior cingulate cortex activation by emotional words: fMRI evidence from a valence decision task

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Apathy: a neuropsychiatric syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

The mesolimbic dopamine reward circuit in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Quality of life in Parkinson's disease: the relative importance of the symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Disconnecting force from money: effects of basal ganglia damage on incentive motivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

[3H]Threo-(+/-)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Emotion-induced changes in human medial prefrontal cortex: II. During anticipatory anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

The nosological position of apathy in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Reliability, validity, and clinical correlates of apathy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

The syndromal validity and nosological position of apathy in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Diagnosis and the premotor phase of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Manic behaviour induced by deep-brain stimulation in Parkinson's disease: evidence of substantia nigra implication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

Treatment of Parkinsonism With Levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ032

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWQ032

1 reference

14 November 2017

1 reference